TrialCNS neuroscience & therapeutics2010

A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson's disease.

Joaquim J Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.